Fresenius Medical Care AG (FMCQF) Cash from Financing Activities (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has reported Cash from Financing Activities for 17 consecutive years, with -$242.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 76.48% year-over-year to -$242.6 million; the TTM figure through Dec 2025 stood at -$1.6 billion (up 41.33% YoY), while the FY2025 annual figure was -$1.6 billion, up 40.51% from the prior year.
• Cash from Financing Activities came in at -$242.6 million for Q4 2025 at Fresenius Medical Care AG, up from -$1.3 billion in the prior quarter.
• The five-year high for Cash from Financing Activities was $89.7 million in Q2 2025, with the low at -$1.3 billion in Q3 2025.
• Average Cash from Financing Activities over 5 years is -$466.1 million, with a median of -$410.7 million recorded in 2021.
• Across the five-year window, Cash from Financing Activities sank 14656.63% in 2024 and soared 109.94% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$409.0 million in 2021, then surged by 70.09% to -$122.3 million in 2022, then plunged by 555.76% to -$802.3 million in 2023, then declined by 28.56% to -$1.0 billion in 2024, then soared by 76.48% to -$242.6 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$242.6 million, -$1.3 billion, and $89.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.